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Objective: Heparin-binding epidermal growth factor (HB-EGF) has pleiotropic biological functions in the
female reproductive tract. HB-EGF has a function in the menstruation cycle, implantation, decidualiza-
tion, placenta development, and also inhibition of apoptosis. This study aims to investigate a possible role
of HB-EGF in missed abortion.
Materials and methods: Decidual and placental tissue samples were obtained from women with un-
wanted pregnancy as the control group and from women with missed abortions as the patient group.
Immunohistochemistry was utilized to compare HB-EGF expression of ﬁbroblast and decidual cells in
uterine decidual stroma and ﬁbroblasts and mesenchymal cells in placental villous stroma; the TUNEL
technique was used to detect apoptotic cells within the decidual and placental tissues of the two groups.
Results: It was demonstrated that HB-EGF expression in both uterine decidual stroma and placenta
stroma was increased in the missed abortion group (142.70 ± 12.80; 116.10 ± 14.16, respectively),
compared with the normal pregnancy group (101.60 ± 14.18; 81.60 ± 10.74, respectively). It was also
shown that there was no difference in TUNEL (Terminal deoxynucleotide transferase dUTP Nick End
Labelling) positive cells between the uterine decidual stroma (11.4 ± 3%; 13.6 ± 3%, respectively),
placental villous stroma (13.7 ± 3%; 15.9 ± 3%, respectively), and cytotrophoblast-syncytiotrophoblast
cells (7.3 ± 2; 9.8 ± 3, respectively) of the two groups.
Conclusion: This data supports the hypothesis that increased HB-EGF expression in a missed abortion
may prevent the discharge of the dead fetus.
Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Missed abortion, which is deﬁned as a nonviable pregnancy that
has been retained in the uterus without spontaneous passage for a
number of weeks since the demise, implies that the uterus has
“missed” recognizing the abnormal pregnancy [1]. Genetic and
uterine abnormalities, endocrine and immunological dysfunctions,
infectious agents, environmental pollutants, psychogenetic factors,
and endometriosis are the most important known causes of missed
abortion [2]. Although previous studies on missed abortion have
mainly focused on diagnosis and treatment of it, we pay attention
to the underlying causal factor.ool of Medicine, Department
5020, Turkey.
ilgin).
bstetrics & Gynecology. PublishedHeparin-binding epidermal growth factor (HB-EGF) is amember
of the EGF family and performs a variety of functions such as cell
growth and differentiation in different cell systems [3]. Although
HB-EGF is synthesized as transmembrane proteins (e.g., proHB-
EGF), the secreted form (e.g., sHB-EGF) binds the cell receptors [4].
HB-EGF has two kinds of receptors which are tyrosine kinase HER/
ErbB receptors and heparan sulfate proteoglycans (HSPG) [3]. HB-
EGF stimulates HER1 and HER4 tyrosine kinase receptors but does
not stimulate HER2 or HER3. HSPG is also necessary as a cofactor for
HB-EGF to bind to its receptors, HER1 and HER4. HB-EGF induces
receptor dimerization and autophosphorylation, leading to down-
stream signaling that affects an extensive array of pathways [5].
HB-EGF has been implicated as a participant in various normal
physiological and pathologic processes such as cell attachments,
chemotaxis, mitosis, and inhibition of cellular apoptosis. HB-EGF
induces cell attachment through HER1 or HER4 [6], chemotaxisby Elsevier Taiwan LLC. All rights reserved.
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lizes both MEK/ERK (Mitogen-activated protein kinase kinase/
extracellular signal-regulated kinases) and PI3K/Akt (Phosphoino-
sitide 3-kinase/ Serine/threonine-speciﬁc protein kinase) pathways
to inhibit cellular apoptosis [8].
HB-EGF also has a central role in the reproductive system of
women during the menstruation cycle [9], implantation, and also
decidualization [10]. HB-EGF mRNA is expressed throughout the
menstrual cycle in humans [11] and is predominantly localized in
the stromal compartment of the endometrium [12,13]. During the
implantation process, HB-EGF is localized on the apical surface of
human luminal epithelial cells and on the surface of pinopodes [14].
HB-EGF also plays an important role in the blastocyst adhesion and
development [15,16].
HB-EGF plays a role in the decidualization of human endometrial
stromal cells, induced via increased levels of prolactin and insulin-
like growth factor binding protein-1 [17], and stimulates stromal
cell growth via HER1 [12]. Decidualization in vivo occurs in response
to steroid hormones, and hormonal control of gene expression in the
endometrium is mediated by cAMP (Cyclic adenosine mono-
phosphate) signaling [18]. In addition, Chobotova et al [17] reported
that HB-EGF and its receptors (EGFR and ErbB4) have a function in
decidualization of the human endometrium. It was reported that the
local application of HB-EGF-soaked beads promotes decidualization
in the mouse uterus [19].
HB-EGF is active during placental development and is present in
the ﬁrst trimester chorionic villi and decidua, in second trimester
villi, and in term placenta [9]. Leach et al [20] reported that HB-EGF
mRNA and protein have been expressed in villous and extravillous
cytotrophoblast cells up to Week 35 of gestation in placentae from
women who delivered preterm, but HB-EGF expression has been
reduced about ﬁve-fold in preeclamptic pregnancies.
HB-EGF contributes signiﬁcantly to the survival of trophoblastic
cells during stress, induced by in vitro culture and can prevent
apoptosis. The elimination of endogenous HB-EGF signaling during
villous explants culture using the antagonist CRM197 signiﬁcantly
increased cell death among villous trophoblast cells [21]. The
antiapoptotic function of HB-EGF is related to growth factors such
as transforming growth factor (TGF)-b and tumor necrosis factor
(TNF)-a, which have growth regulatory effects in both epithelial
and stromal cells. TNFa and TGFb signiﬁcantly increase the levels of
HB-EGF and implicate apoptosis in endometrial stromal cells [17].
Although HB-EGF and its receptors mediate the receptivity,
maturation, and decidualization of endometrium, it facilitates the
implantation and development of both placenta and embryo, but
its function on missed abortion is not completely known. In this
study, our aim is to determine the possible modulatory effects of
HB-EGF on missed abortion and how to prevent the discharge of
the dead fetus.
Materials and methods
Fifteen unwanted pregnancy (5e10 weeks gestational age) and
19 missed abortion (6e11 weeks gestational age) endometrial tis-
sue samples were obtained with informed consent and in accor-
dancewith the requirements of the Ethics Committee of Celal Bayar
University, Manisa, Turkey. The mean age of women was 27.53
years (range 21e37 years) for the normal pregnancy group and
28.74 years (range 18e41 years) for the missed abortion group.
Abortions were diagnosed by transvaginal ultrasound and were
conﬁrmed by repeat ultrasound prior to the dilation and curettage
procedure. Chorionic villi and maternal decidua were separated
and cleaned. Placental and decidual tissues were ﬁxed in 10%
buffered formalin solution and embedded in parafﬁn. The blocks
were cut in 4e5 mm thick serial sections. The ﬁrst sections of tissuewere stained with HB-EGF primary antibody by means of an
immunohistochemical technique and the second sections of tissue
were stained by means of the TUNEL technique.Immunohistochemistry
Formalin-ﬁxed, parafﬁn-embedded sections were used for
immunohistochemical staining. The tissue samples were stored at
60C overnight and were then dewaxed by xylene for 30 minutes.
After dehydration of sections with ethanol, they were washed with
distilled water. They were then treated with 2% trypsin (ab970,
Abcam, Cambridge, UK) at 37C for 15 minutes and incubated in 3%
H2O2 solution for 15 minutes to inhibit endogenous peroxidase
activity. Then, the sections were incubated with anti-Hb-EGF pri-
mary antibody (sc-1414; Santa Cruz, CA, USA) in a 1/100 dilution for
18 hours at þ4C. They were given three additional 5-minute
washes in PBS (Phosphate buffered saline), followed by incubation
with biotinylated immunoglobulin G and administration of strep-
tavidin peroxidase (Histostain Plus kit Zymed 87-9999; Zymed, San
Francisco, CA, USA). After washing the secondary antibodywith PBS
three times for 5 minutes, the sections were stained with DAB
Substrate system containing diaminobenzidine (DAB, K007, DBS,
Pleasanton, CA, USA) to detect the immunoreactivity, and thenwere
stained with Mayer's hematoxylin (72804E, Microm, Walldorf,
Germany) for counterstaining. They were covered with mounting
medium (01730 Surgipath, Cambridge, UK) and observed with light
microscopy (Olympus BX-40, Tokyo, Japan).
Immunohistochemical staining for HB-EGF was jointly scored
on all cases using a semiquantitative system that is based on the H
index [22]. Immunostaining intensity was categorized into the
following scores: 0 (no staining), 1 (weak, but detectable staining),
2 (moderate staining), and 3 (intense staining). The H-score value
was derived for each specimen by calculating the sum of the per-
centage of cells for ﬁbroblast and decidual cells in uterine decidual
stroma and ﬁbroblasts and mesenchymal cells in placental villous
stroma. Categorized by intensity of staining, multiplied by its
respective score, by means of the formula:
H score ¼
X
Piðiþ 1Þ; (1)
where i ¼ intensity of staining with a value of 1, 2, or 3 (weak,
moderate, or strong, respectively) and Pi is the percentage of
stained epithelial cells for each intensity, varying from 0% to 100%.
For each slide, ﬁve different ﬁelds were evaluated microscopically
at 200  magniﬁcation. H-score evaluation was performed by at
least two investigators (K.O., S.V., F.K.) independently, blinded to
the source of the samples as well as to each other's results and the
average score was utilized.TUNEL staining
We used the in situ apoptosis detection kit (DeadEnd Colori-
metric TUNEL system, Millipore, S7100, USA & Canada) in order
to detect apoptosis. Sections (5 mm) were cut from parafﬁn blocks
of decidual and placental samples of the two groups. The sections
were deparafﬁnized in xylene, rehydrated, and incubated with
20 mg/mL proteinase K for 10 minutes and rinsed in distilled
water. Endogenous peroxidase activity was inhibited with 3%
hydrogen peroxide. The sections were incubated with equilibra-
tion buffer for 10e15 seconds and TdT enzyme in a humidiﬁed
atmosphere at 37C for 60 minutes. They were put into pre-
warmed working strength stop/wash buffer at room temperature
for 10 minutes subsequently and incubated with anti-
streptavidineperoxidase for 45 minutes. The staining was done
Fig. 1. The analysis of apoptosis in TUNEL labeling cells from normal pregnancy (A, D) and missed abortion group (B, E). A few apoptotic cells' nuclei (arrows) are stained with red
and were seen in the decidua (A, B) and placenta (D, E). Stromal cells (arrows), syncytiotrophoblast-cytotrophoblast cells (arrowheads), stromal cells (arrows), negative control (C),
and positive control (F) for TUNEL (Terminal deoxynucleotide transferase dUTP Nick End Labelling) (arrow) are also shown. Original magniﬁcation: A, B, D, E  200; C, F  400.
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toxylin. As a negative staining control, TdT was omitted during
the tailing reactions (Fig. 1C) and as a positive staining control
have been used the lymphoid tissue section (according to the
manufacturer's instructions; Fig. 1F). The apoptotic cells were
counted from ﬁve areas in each section in a blinded manner, to
determine the apoptotic rate. The relative incidence of apoptotic
cells was calculated as:
ð%Þ ¼ number of TUNEL stained nuclei in a zone=
number of hematoxylin stained nuclei in
the same zone 100:
(2)Statistical analysis
Immunohistochemical values (mean ± SD) and the number of
TUNEL positive cells data are summarized in Table 1. The compar-
ison between the two groups was performed means of the Man-
neWhitney U test. A p value <0.05 was considered signiﬁcant.Table 1
H-score values of heparin-binding epidermal growth factor (HB-EGF) positive cells and n
Group HB-EGF uterine
decidual stroma
HB-EGF placental
villous stroma
T
d
Normal Mean ± SD 101.6 ± 14.18* 81.6 ± 10.74* 1
pregnancy Median 100.50 85.00 1
Missed Mean ± SD 142.70 ± 12.80* 116.10 ± 14.16* 1
abortion Median 145,50 116.00 1
Total Mean ± SD 122.15 ± 24.84 98.85 ± 21.51 1
Median 121.00 95.50 1
p <0.0001 <0.0001 0
*p < 0.01, ManneWhitney U test.Statistical analysis was performed via SPSS statistical software,
version 10.0 for Windows (SPSS Inc., Chicago, IL, USA). Error bars of
H-score of HB-EGF expression and the number of TUNEL positive
cells (%) are shown in Figs. 2 and 3, respectively.
Results
HB-EGF immunoreactivity was evaluated in both uterine
decidual stroma and placental villous stroma of the normal
pregnancy and the missed abortion groups. The H-scores of HB-
EGF staining ﬁbroblasts and decidual cells in the uterine decidual
stroma were higher in the missed abortion group (142.70 ± 12.80)
than the normal pregnancy group (101.6 ± 14.18; Table 1 and
Figs. 2A, 4A, and 4B). The staining of ﬁbroblasts and mesenchymal
cells for HB-EGF was also lower in the placental villous stroma in
the normal pregnancy group (81.6 ± 10.74) than in the missed
abortion group (116.10 ± 14.16; Table 1 and Figs. 2B, 4C, and 4D).
We used the TUNEL assay to identify apoptotic cells by immu-
nocytochemistry for both normal pregnancy and missed abortion
groups. Values of TUNEL positive ﬁbroblast and decidual cells in theumber of TUNEL positive cells in missed abortion.
UNEL uterine
ecidual stroma
TUNEL placental
villous stroma
TUNEL placenta
cytotrophoblast-syncytiotrophoblast
1.4 ± 3 13.7 ± 3 7.3 ± 2
0 1.3 7.5
3.6 ±,3 15.9 ± 3 9.8 ± 3
4.5 0.165 8.5
2.5 ± 3 148 ± 3 8.5 ± 3
2 15.5 8
.092 0.159 0.077
Fig. 2. Error bars of heparin-binding epidermal growth factor (HB-EGF) expression in uterine decidual stroma (A) and placental villous (B).
Fig. 3. Error bars of TUNEL (Terminal deoxynucleotide transferase dUTP Nick End Labelling) positive cells in uterine decidual stroma (A), placental villous stroma (B), and cyto-
trophoblastesyncytiotrophoblast cells (C).
Fig. 4. The expression of heparin-binding epidermal growth factor (HB-EGF) in ﬁbroblast (arrow) and decidual cells (arrowhead) in decidual stroma in normal pregnancy (A) and
missed abortion group (B), and ﬁbroblasts (arrow) and mesenchymal cells (arrowhead) in placental stroma in normal pregnancy (C) and in missed abortion group (D) by
immunohistochemistry. The most intense immunoreactivities of HB-EGF were detected in the missed abortion group (B, D) rather than the normal pregnancy group (A, C). Original
magniﬁcation  400 (A, B),  200 (C, D).
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group and 13.6 ± 3% the missed abortion group (Table 1 and
Figs. 1A, 1D, and 3A). However, similar TUNEL positive cells of
placental villous stromal cells were in the normal pregnancy
(13.7 ± 3%) and missed abortion (15.9 ± 3%) groups (Table 1 and
Figs. 1B, 1E, and 3B). In the placenta, TUNEL-positive syncytio-
trophoblast-cytotrophoblast cells are 7.3 ± 2% in the normal preg-
nancy group (Fig. 1D) and 9.8 ± 3% in the missed abortion group
(Table 1 and Figs. 1C, 1F, and 3C). There was no difference in TUNEL
positive cell counts for both decidua and placenta cells between the
two groups (Table 1 and Fig. 3).
Discussion
We demonstrated that there was a statistical signiﬁcance in the
immunohistochemical staining density of HB-EGF staining cells but
therewas no statistical signiﬁcance of TUNEL positive cells between
the normal fertile women (control) group and the missed abortion
group. The current study claimed that in addition to the initiation of
the pregnancy role, the HB-EGF may play crucial roles in the pre-
vention of the discharge of the dead fetus.
HB-EGF performs two simultaneous functions during the human
implantation as an attachment factor and a growth factor [23]. Itwas
reported that HB-EGF plays an important role in the preparation of
the uterine luminal epithelium for blastocyst attachment at the
beginning of pregnancy [13]. HB-EGF, as a growth factor, accelerates
the development of human embryos to the blastocyst stage and
their subsequent hatching from the zona pellucida [24]. HB-EGF, as
an attachment factor, upregulates many important proteins
expressed from a uterine luminal epithelial surface such as integrin
b3, leukemia inhibitory factor (LIF), and HOXA10 [25]. Integrin avb3
serves for osteopontin to mediate the embryo attachment [26]. LIF
stimulates human embryo development to the blastocyst stage [27]
and is required for embryo implantation [28]. HOXA10was found in
the human endometrium during the mid-secretory phase abun-
dantly and may be involved in implantation and decidualization of
endometriumduring early pregnancy [29]. HOXA10 induction by P4
during the window of implantation leads to a blockage in the stro-
mal cell cycle, facilitating decidualization [30].
Previous studies reported that HB-EGF plays a role in the
decidualization of human endometrial stromal cells [31]. Our
immunohistochemical results showed HB-EGF expression was
found on the decidual cells of both groups, but they were more
intense in the missed abortion group (Figs. 3A, 4A, and 4B). Cho-
botova et al [17] reported that endometrial stromal cells are treated
with 8-Br-cAMP, which is known to artiﬁcially induce deciduali-
zation; the soluble form of HB-EGF is upregulated. It was reported
that two different inhibitors of HB-EGF activity, the diphtheria toxin
analogue CRM197 and neutralizing HB-EGF antibodies, result in
decreased levels of prolactin and insulin-like growth factor-binding
protein-1. It was suggested that HB-EGF induces decidualization
through the increase of stromal cell production of prolactin and
insulin-like growth factor binding protein-1 [17]. In addition, Kar-
povich et al [32] reported that HB-EGF could result from the
upregulation of interleukin (IL)-11 secretion, which plays a role in
the decidualization process in mice. However, female mice without
the IL-11Ra gene are infertile due to defective differentiation of the
stroma in response to an implanting blastocyst, leading to the
resorption of the embryo [33].
A successful pregnancy in humans depends on the deep inva-
sion of the maternal decidua by extravillous trophoblast cells
(EVTs), a process regulated by autocrine and paracrine signals in the
decidual-trophoblast microenvironment. Gonzalez et al [34] re-
ported that decidual cells are the biosensors for embryo quality and
placed HB-EGF and IL-1b among the critical factors indicative of theselective response. We found that HB-EGF expression in the uterine
decidual stromal areas is higher in the missed abortion group than
in the fertile group (Figs. 3A, 4A, and 4B) and suggest that HB-EGF
expression might support the stroma integrity, thus preventing the
discharge of the dead fetus. HB-EGF may have a mitogenic function
in the human endometrial cells, as well as an invasion function in
trophoblastic cells. HB-EGF induces mitosis for ﬁbroblasts and
smooth muscle cells and contributes to wound healing [3,35] for
endometrial stromal cells and many other cell types [12]. HB-EGF is
also considered to be important in trophoblast invasion and
placental development leading to enhanced cell migration [36].
When supplementing co-cultures of undifferentiated ESC and
trophoblast spheroids with HB-EGF, undifferentiated ESC provides
a matrix that, in conjunction with HB-EGF, becomes optimized to
support trophoblast spreading [3].
HB-EGF expressionwas observed to exist both in uterine decidual
stromaand inplacental villous stromaof the twogroups (Figs. 3A, 3B,
4A, and 4D), which indicates that HB-EGF is a survival factor during
the establishment of pregnancy and placental development [17].
Birdsall et al [9] reported that HB-EGF is abundant in placental tissue
during all three trimesters. The extensive expression of HB-EGF in
trophoblasts could be vital for their invasive activities during preg-
nancy [20]. It is known that the paucityofHB-EGF inplacenta leads to
preeclampsia [37]. However, an addition of HB-EGF to term villous
explants cultured at 2% O2 inhibits trophoblast apoptosis, demon-
strating its persistent role as a survival factor [21]. These ﬁndings
highlighted the importance of HB-EGF in success of early placenta-
tion and in protecting trophoblast cells from the damaging effects of
hypoxia encountered throughout gestation.
HB-EGF protects from apoptosis and is accepted as a survival
factor [17]. In this study, we observed very rare TUNEL positive cells
in the normal pregnancy group (Fig. 2A and D) and in the missed
abortion group (Fig. 2B and E). There was no signiﬁcant difference
in TUNEL positive cells between two groups, which suggests that
minimal apoptosis may maintain pregnancy and prevent from
abortion. By contrast, the increased expression of FasL in decidual
lymphocytes, the expression of Fas in EVT and the apoptosis of
interstitial EVT in situ have been reported in spontaneous abortion
of humans [38]. It is known that the dysregulation of HB-EGF and
the deﬁciencies in trophoblast function could lead to preeclampsia.
Although it remains to be determined during the course of gesta-
tion, HB-EGF levels are found to be reduced in preeclamptic preg-
nancies for the ﬁrst time. Trophoblast invasion is shallow in
preeclampsia, possibly due to the lack of HB-EGF-induced cell
migration and the rise in apoptosis, exacerbated by reduced cyto-
protection. Patients delivering preterm without hypertensive dis-
order produce placentae with normal levels of HB-EGF [20].
It is known that placentation is initiated in a low oxygen envi-
ronment and hypoxia leads to apoptotic death. By means of speciﬁc
antagonists of HB-EGF signaling, it can be demonstrated that HB-
EGF inhibits apoptosis due to hypoxia. Hung et al [39] demon-
strated that reactive oxygen species are generated in vitro in a
reoxygenation injury model, leading to apoptosis of the tropho-
blasts [40]. HB-EGF can also prevent apoptosis induced by reox-
ygenation injury in HTR-8/SVneo cells by signaling through its
receptors, HER1 and HER4 [41]. Although HB-EGF is downregulated
within 30 minutes of elevating the O2 concentration from 2% to
20%, accumulated sHB-EGF generated by trophoblasts at low oxy-
genmay protect against a sudden exposure to oxygenatedmaternal
blood in the uterine environment. By contrast, only HB-EGF inhibits
apoptosis in cytotrophoblasts cultured at low oxygen [42]. It is
proposed that insults such as reoxygenation injury are not always
tolerated and can lead to placental pathologies [43]. The activity of
the EGF signaling system could be a critical variable that keeps
oxidative stress in check.
K. Ozbilgin et al. / Taiwanese Journal of Obstetrics & Gynecology 54 (2015) 13e1818Previous studies reported that decreased levels of HB-EGF leads
to pregnancy complications such as preeclampsia and small
gestational age, due to aberrant trophoblast invasion [44] and also
to intrauterine growth restriction due to elevated apoptosis [45].
Current data demonstrated that high HB-EGF expression is found in
two important tissue types (decidual and trophoblastic cells), and
TUNEL positive cells are very low in both groups. In light of these
observations, HB-EGF acts as a decidualization factor, a tropho-
blastic invasion modulator, and a potent cytoprotective agent in
both groups.Conﬂicts of interest
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